IP Library Granted Patent US 12,480,101
Granted Patent B2
US 12,480,101 · App. 17/631,429 · Granted Nov 25, 2025

Modified host cells for high efficiency production of vanillin

Inventors: Lauren Raetz (Emeryville, CA); Chad Hansen (Emeryville, CA)
Assignee: AMYRIS, INC.
C12N9/0008C07C47/58C12P7/24C12Y102/01003
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,480,101
App. No.
17/631,429
Granted
Nov 25, 2025
Kind
B2
Abstract

Provided herein are genetically modified host cells, compositions, and methods for improved production of vanillin and/or glucovanillin. The host cells, compositions, and methods described herein provide an efficient route for the heterologous production of vanillin and/or glucovanillin and any compound that can be synthesized or biosynthesized from either or both.

Claims (24)

1 . A genetically modified Saccharomyces cerevisiae host cell that produces vanillin or glucovanillin, the host cell comprising:

(i) deletion of a homolog of fatty aldehyde dehydrogenase (HFD1) gene; and

(ii) one or more nucleic acids expressing:

a catechol-O-methyltransferase (COMT);

an aromatic carboxylic acid reductase (ACAR) from Nocardia iowensis;

a phosphopantetheinyl transferase (PPTASE); and

a Podospora pauciseta 3-dehydroshikimate dehydratase (AroZ),

wherein the host cell does not express an Hfd1 protein.

2 . The genetically modified Saccharomyces cerevisiae host cell of claim 1 , further comprising deletion of an ADH6 gene.

3 . The genetically modified Saccharomyces cerevisiae host cell of claim 1 , further comprising deletion of a GRE2 gene.

4 . The genetically modified Saccharomyces cerevisiae host cell of claim 1 , further comprising deletion of a YGL039W gene.

5 . The genetically modified Saccharomyces cerevisiae host cell of claim 1 , further comprising one or more nucleic acids expressing a 3-dehydroquinate synthase (AroB) or a dehydroquinate dehydratase (AroD).

6 . The genetically modified Saccharomyces cerevisiae host cell of claim 1 , further comprising one or more nucleic acids expressing an AroB, an AroD, or a phospho-2-dehydro-3-deoxyheptonate aldolase (AroF).

7 . The genetically modified Saccharomyces cerevisiae host cell of claim 1 , further comprising one or more nucleic acids expressing an E. coli AroB, an E. coli AroD, and an E. coli AroF.

8 . The genetically modified Saccharomyces cerevisiae host cell of claim 1 , wherein the PPTASE is a Corynebacterium glutamicum PPTASE.

9 . The genetically modified Saccharomyces cerevisiae host cell of claim 1 , further comprising one or more nucleic acids expressing an eugenol alcohol oxidase (EAO).

10 . The genetically modified Saccharomyces cerevisiae host cell of claim 1 , further comprising one or more nucleic acids expressing a Rhodococcus jostii EAO.

11 . The genetically modified Saccharomyces cerevisiae host cell of claim 1 , further comprising one or more nucleic acids expressing an Arabidopsis thaliana UDP-glycosyltransferase (UGT).

12 . The genetically modified Saccharomyces cerevisiae host cell of claim 1 , wherein the one or more nucleic acids are expressed from an inducible promoter.

13 . The genetically modified Saccharomyces cerevisiae host cell of claim 12 , wherein the inducible promoter is a GAL promoter.

14 . The genetically modified Saccharomyces cerevisiae host cell of claim 12 , wherein the one or more nucleic acids are expressed from a GAL promoter, and wherein the genetically modified Saccharomyces cerevisiae host cell comprises a yeast GAL80 gene expressed from a maltose-responsive promoter.

15 . A method for producing vanillin or glucovanillin, comprising the steps of:

a. culturing the genetically modified Saccharomyces cerevisiae host cell of claim 1 in a medium with a carbon source under conditions suitable for making vanillin or glucovanillin; and

b. recovering said vanillin or glucovanillin from the medium.

Assignments (7)
SECURITY INTEREST Recorded Jan 9, 2026
From: AMYRIS, INC.
To: EUAGORE, LLC
Reel/Frame 073419/0255 →
SECURITY INTEREST Recorded May 24, 2024
From: AMYRIS, INC.
To: EUAGORE, LLC
Reel/Frame 067528/0467 →
SECURITY INTEREST Recorded Aug 17, 2023
From: AMYRIS, INC.; AMYRIS CLEAN BEAUTY, INC.; AMYRIS FUELS, LLC; AB TECHNOLOGIES LLC; APRINNOVA, LLC; AMYRIS-OLINKA, LLC; ONDA BEAUTY INC.; UPLAND 1 LLC; AMYRIS ECO-FAB LLC; CLEAN BEAUTY 4U HOLDINGS, LLC; AMYRIS CLEAN BEAUTY LATAM LTDA; INTERFACES INDUSTRIA E COMERCIA DE COSMETICOS LTDA; AMYRIS BIOTECHNOLOGIA DO BRASIL LTDA; AMYRIS EUROPE TRADING B.V. (NETHERLANDS); AMYRIS BIO PRODCUTS PORTUGAL, UNIPESSOAL, LDA; BEAUTY LABS INTERNATIONAL LIMITED; AMYRIS UK TRADING LIMITED
To: EUAGORE, LLC
Reel/Frame 064619/0778 →
SECURITY INTEREST Recorded Aug 3, 2023
From: AMYRIS CLEAN BEAUTY, INC.; AMYRIS FUELS, LLC; AB TECHNOLOGIES LLC; AMYRIS, INC.
To: MUIRISC, LLC
Reel/Frame 064492/0518 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 6, 2023
From: GIVAUDAN SA
To: AMYRIS, INC.
Reel/Frame 062311/0688 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 22, 2022
From: RAETZ, LAUREN; HANSEN, CHAD
To: AMYRIS, INC.; GIVAUDAN SA
Reel/Frame 061855/0809 →
SECURITY INTEREST Recorded Oct 18, 2022
From: AMYRIS, INC.
To: FORIS VENTURES, LLC
Reel/Frame 061703/0499 →
Continuity (2)
Provisional Application 62881874 · Aug 1, 2019
Related Publication 20220282226A1 · Sep 8, 2022
References Cited (20)
US 20140245496A1 · Hansen et al. · 2014 [cited by applicant]
EP 2957629A1 · 2015 [cited by applicant]
WO WO2015009558A1 · 2015 [cited by applicant]
Sousa et al., Microbiology 148(Pt5):1291-1303, 2002. [cited by examiner]
Witkowski et al., Biochemistry 38:11643-11650, 1999. [cited by examiner]
Tang et al., Phil Trans R Soc B 368:20120318, 1-10, 2013. [cited by examiner]
Seffernick et al., J. Bacteriol. 183(8):2405-2410, 2001. [cited by examiner]
Singh et al., Current Protein and Peptide Science 19(1):5-15, 2018. [cited by examiner]
Sadowski et al., Current Opinion in Structural Biology 19:357-362, 2009. [cited by examiner]
d'Espaux et al., Metabolic Engineering 42:115-125, 2017. [cited by examiner]
Chan et al., “Regulation of S-Adenosylmethionine Levels in [cited by applicant]
International Search Report and Written Opinion of PCT/US2020/044613 dated Nov. 19, 2020; 16 pages. [cited by applicant]
Christian Fleige et al., “Metabolic Engineering of the Actinomycete [cited by applicant]
Diana Di Gioia et al., “Metabolic engineering of Pseudomonas fluorescens for the production of vanillin from ferulic acid”, Journal Of Biotechnology, vol. 156, No. 4, Aug. 22, 2011, pp. 309-316. [cited by applicant]
Esben H Hansen et al., “De Novo Biosynthesis of Vanillin in Fission Yeast ( [cited by applicant]
Garcia-Bofill Miquel et al., “Enzymatic synthesis of vanillin catalysed by an eugenol oxidase”, Applied Catalysis A: General, Elsevier, Amsterdam, NL, vol. 582, Jul. 25, 2019. [cited by applicant]
Nils J. H. Averesch et al., “Metabolic Engineering of the Shikimate Pathway for Production of Aromatics and Derived Compounds-Present and Future Strain Construction Strategies”, Frontiers In Bioengineering and Biotechno… [cited by applicant]
Paul D. Sainsbury et al., “Breaking Down Lignin to High-Value Chemicals: The Conversion of Lignocellulose to Vanillin in a Gene Deletion Mutant of Rhodococcus jostii RHA1”, CS Chemical Biology, vol. 8, No. 10, Jul. 30, … [cited by applicant]
R. Plaggenborg et al., “Functional analyses of genes involved in the metabolism of ferulic acid in Pseudomonas putida KT2440”, Applied Microbiology And Biotechnology, vol. 61, No. 5-6, Mar. 27, 2003, pp. 528-535. [cited by applicant]
Yongjin J. Zhou et al., “Production of fatty acid-derived oleochemicals and biofuels by synthetic yeast cell factories”, Nature Communications, vol. 7, No. 1, May 25, 2016. [cited by applicant]